125 related articles for article (PubMed ID: 37579733)
1. Use of Immunohistochemical p53 Mutant-Phenotype in Diagnosis of High-Grade Dysplasia of Esophageal Squamous Epithelia.
Xu YJ; Li R; Chen JM; Zhuang XY; Lin N; Wang LP; Zeng BW
Dig Dis; 2023; 41(5):685-694. PubMed ID: 37579733
[TBL] [Abstract][Full Text] [Related]
2. Ki-67 and ProExC are useful immunohistochemical markers in esophageal squamous intraepithelial neoplasia.
Wang WC; Wu TT; Chandan VS; Lohse CM; Zhang L
Hum Pathol; 2011 Oct; 42(10):1430-7. PubMed ID: 21420715
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of vocal cord polyps applying markers of squamous cell carcinogenesis.
Braut T; Krstulja M; Marijić B; Maržić D; Kujundžić M; Brumini G; Vučinić D; Oštarijaš E
Pathol Res Pract; 2019 Jan; 215(1):144-150. PubMed ID: 30455127
[TBL] [Abstract][Full Text] [Related]
4. Abnormal p53 Immunohistochemical Patterns Shed Light on the Aggressiveness of Oral Epithelial Dysplasia.
Novack R; Zhang L; Hoang LN; Kadhim M; Ng TL; Poh CF; Kevin Ko YC
Mod Pathol; 2023 Jul; 36(7):100153. PubMed ID: 36906072
[TBL] [Abstract][Full Text] [Related]
5. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
[TBL] [Abstract][Full Text] [Related]
6. Expressions of PCNA, p53, p21(WAF-1) and cell proliferation in fetal esophageal epithelia: comparative study with adult esophageal lesions from subjects at high-incidence area for esophageal cancer in Henan, North China.
Xing Y; Ning Y; Ru LQ; Wang LD
World J Gastroenterol; 2003 Jul; 9(7):1601-3. PubMed ID: 12854173
[TBL] [Abstract][Full Text] [Related]
7. DNA ploidy, P53 expression, and cellular proliferation in normal epithelium and squamous dysplasia of non-cancerous and cancerous human oesophagi.
Itakura Y; Sasano F; Date F; Kato K; Sekine H; Mori S; Nagura H
Anticancer Res; 1996; 16(1):201-8. PubMed ID: 8615609
[TBL] [Abstract][Full Text] [Related]
8. [Spindle cell type squamous dysplasia of the esophagus: a clinicopathological analysis].
Hou WH; Shen MQ; Hou WD; Zhang XL; Niu JW; Zhou SL; Jin ML
Zhonghua Bing Li Xue Za Zhi; 2021 Oct; 50(10):1128-1133. PubMed ID: 34619865
[No Abstract] [Full Text] [Related]
9. [Clinicopathological features of basal cell type dysplasia of esophagus].
Hou WH; Duan XK; Hou WD; Ma LJ; Niu JW; Zhou SL; Jin ML
Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):638-644. PubMed ID: 34078053
[No Abstract] [Full Text] [Related]
10. [Clinicopathological features of basal cell layer type high-grade squamous dysplasia of the esophagus].
Hou WH; Duan XK; Hou WD; Shen MQ; Zhang XL; Liu YF; Jin ML
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):236-241. PubMed ID: 33677888
[No Abstract] [Full Text] [Related]
11. p53 immunoexpression: an aid to conventional methods in the screening of precursor lesions of squamous esophageal cancer in patients at high-risk?
Fagundes RB; Melo CR; Pütten AC; Moreira LF; de Barros SG
Cancer Detect Prev; 2005; 29(3):227-32. PubMed ID: 15936591
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical evaluation of p53, FHIT, and IGF2 gene expression in esophageal cancer.
Chava S; Mohan V; Shetty PJ; Manolla ML; Vaidya S; Khan IA; Waseem GL; Boddala P; Ahuja YR; Hasan Q
Dis Esophagus; 2012 Jan; 25(1):81-7. PubMed ID: 21668571
[TBL] [Abstract][Full Text] [Related]
13. Atypical regenerative hyperplasia of the esophagus in endoscopic biopsy: a mimicker of squamous esophagic carcinoma.
Arista-Nasr J; Rivera I; Martinez-Benitez B; Bornstein-Quevedo L; Orozco H; Lugo-Guevara Y
Arch Pathol Lab Med; 2005 Jul; 129(7):899-904. PubMed ID: 15974813
[TBL] [Abstract][Full Text] [Related]
14. Predicting malignant transformation of esophageal squamous cell lesions by combined biomarkers in an endoscopic screening program.
Zhang H; Li H; Ma Q; Yang FY; Diao TY
World J Gastroenterol; 2016 Oct; 22(39):8770-8778. PubMed ID: 27818592
[TBL] [Abstract][Full Text] [Related]
15. Predictive modelling for the diagnosis of oral and laryngeal premalignant and malignant lesions using p53 and Ki-67 expression.
Jeong JS; Cho KJ; Lee HJ; Roh J; Lee YS; Song JS
Pathology; 2023 Dec; 55(7):945-957. PubMed ID: 37544878
[TBL] [Abstract][Full Text] [Related]
16. p53 protein immunoexpression in esophageal squamous cell carcinoma and adjacent epithelium.
Chaves P; Pereira AD; Pinto A; Oliveira AG; Queimado L; Gloria L; Cardoso P; Mira FC; Soares J
J Surg Oncol; 1997 May; 65(1):3-9. PubMed ID: 9179260
[TBL] [Abstract][Full Text] [Related]
17. Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions.
Shi ST; Yang GY; Wang LD; Xue Z; Feng B; Ding W; Xing EP; Yang CS
Carcinogenesis; 1999 Apr; 20(4):591-7. PubMed ID: 10223186
[TBL] [Abstract][Full Text] [Related]
18. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
[TBL] [Abstract][Full Text] [Related]
19. Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status.
Tessier-Cloutier B; Kortekaas KE; Thompson E; Pors J; Chen J; Ho J; Prentice LM; McConechy MK; Chow C; Proctor L; McAlpine JN; Huntsman DG; Gilks CB; Bosse T; Hoang LN
Mod Pathol; 2020 Aug; 33(8):1595-1605. PubMed ID: 32203095
[TBL] [Abstract][Full Text] [Related]
20. p53 protein in esophageal mucosa of individuals at high risk of squamous cell carcinoma of the esophagus.
Fagundes RB; Mello CR; Tollens P; Pütten AC; Wagner MB; Moreira LF; Barros SG
Dis Esophagus; 2001; 14(3-4):185-90. PubMed ID: 11869317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
